Hong-Yu Zhang, Yan-Yan Gu, Zeng-Gang Li, Yu-Hong Jia, Lan Yuan, Shu-Yan Li, Guo-Shun An, Ju-Hua Ni, Hong-Ti Jia
8-Chloro-adenosine (8-Cl-Ado) is a potent chemotherapeutic agent whose cytotoxicity in a variety of tumor cell lines has been widely investigated. However, the molecular mechanisms are uncertain. In this study, we found that exposure of human lung cancer cell lines A549 (p53-wt) and H1299 (p53-depleted) to 8-Cl-Ado induced cell arrest in the G2/M phase, which was accompanied by accumulation of binucleated and polymorphonucleated cells resulting from aberrant mitosis and failed cytokinesis. Western blotting showed the loss of phosphorylated forms of Cdc2 and Cdc25C that allowed progression into mitosis. Furthermore, the increase in Ser10-phosphorylated histone H3-positive cells revealed by fluorescence-activated cell sorting suggested that the agent-targeted cells were able to exit the G2 phase and enter the M phase. Immunocytochemistry showed that microtubule and microfilament arrays were changed in exposed cells, indicating that the dynamic instability of microtubules and microfilaments was lost, which may correlate with mitotic dividing failure. Aberrant mitosis resulted in mitotic catastrophe followed by varying degrees of apoptosis, depending on the cell lines. Thus, 8-Cl-Ado appears to exert its cytotoxicity toward cells in culture by inducing mitotic catastrophe.
Blood. 1998 Oct 15;92(8):2893-8
[PMID:
9763575]
J Cell Sci. 2000 Nov;113 Pt 21:3681-2
[PMID:
11034894]
Cancer Res. 1989 Oct 15;49(20):5650-5
[PMID:
2676146]
Neoplasia. 2000 Sep-Oct;2(5):441-8
[PMID:
11191111]
Clin Cancer Res. 2002 Aug;8(8):2735-41
[PMID:
12171907]
J Cell Biol. 1995 Jan;128(1-2):117-25
[PMID:
7822409]
Neurosci Lett. 2003 Dec 4;352(2):105-8
[PMID:
14625034]
Curr Biol. 1998 Jul 30-Aug 13;8(16):903-13
[PMID:
9707401]
J Biol Chem. 2001 Jun 15;276(24):21529-37
[PMID:
11278991]
Cancer Res. 2003 Nov 15;63(22):7968-74
[PMID:
14633728]
Clin Cancer Res. 1995 Apr;1(4):377-84
[PMID:
9815994]
Int J Cancer. 2001 Jul 1;93(1):33-41
[PMID:
11391618]
Science. 1994 Dec 16;266(5192):1821-8
[PMID:
7997877]
Nat Cell Biol. 1999 Jul;1(3):E73-9
[PMID:
10559915]
J Biol Chem. 1993 Mar 15;268(8):5774-82
[PMID:
8449943]
Cancer Invest. 2002;20(7-8):972-82
[PMID:
12449730]
Cancer Res. 2001 Jul 15;61(14):5474-9
[PMID:
11454694]
Cancer Res. 1993 Jan 15;53(2):393-400
[PMID:
8380255]
Nature. 2003 May 29;423(6939):493, 495
[PMID:
12774110]
Nature. 2003 Apr 17;422(6933):753-8
[PMID:
12700769]
Prog Cell Cycle Res. 2000;4:107-14
[PMID:
10740819]
Nature. 2003 Apr 17;422(6933):746-52
[PMID:
12700768]
J Clin Invest. 1999 Dec;104(12):1645-53
[PMID:
10606615]
Nature. 2001 May 3;411(6833):102-7
[PMID:
11333986]
Nature. 2000 Jul 27;406(6794):430-5
[PMID:
10935642]
Cancer Res. 2001 Feb 15;61(4):1327-33
[PMID:
11245429]
Chromosoma. 1997 Nov;106(6):348-60
[PMID:
9362543]
Drug Resist Updat. 2001 Oct;4(5):303-13
[PMID:
11991684]
Cell. 2003 Apr 4;113(1):87-99
[PMID:
12679037]
Oncogene. 2003 Sep 1;22(37):5834-47
[PMID:
12947390]
Nat Cell Biol. 2000 Feb;2(2):90-5
[PMID:
10655588]
Exp Cell Res. 2000 Mar 15;255(2):321-6
[PMID:
10694447]
Exp Cell Res. 2000 Aug 25;259(1):64-78
[PMID:
10942579]
Cell Res. 2002 Dec;12(5-6):395-400
[PMID:
12528897]
Nature. 2003 Aug 28;424(6952):1074-8
[PMID:
12904818]
Methods Cell Biol. 1999;61:267-95
[PMID:
9891320]
Clin Cancer Res. 2001 Feb;7(2):320-30
[PMID:
11234887]
Cancer Res. 1992 Jul 15;52(14):3994-9
[PMID:
1617676]
Nucleosides Nucleotides Nucleic Acids. 2002;21(8-9):599-617
[PMID:
12484453]
Anticancer Drugs. 1992 Oct;3(5):485-91
[PMID:
1450443]
